Proton therapy has been a tough sell for payers, but recent $ 25 million Oklahoma decision against Aetna may make them reconsider coverage for the spreading radiation therapy technique. Proton Tx Considered Best Choice According to the Associated Press, jurors believed Aetna reckless disregarded its duty to deal fairly and in good faith with Orrana Cunningham. […]
The post Failure to Approve Proton Tx Costs Aetna $ 25 M appeared first on AAPC Knowledge Center.